Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study

Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study

<p>Abstract</p> <p>Background</p> <p>Whether paricalcitol (PCT) reduces proteinuria in the presence of intensified inhibition of Renin-Angiotensin-System (RAS) is poorly studied. We evaluated the antiproteinuric effect of PCT in non-dialysis chronic kidney disease (CKD)...

Full description

Bibliographic Details
Main Authors: De Nicola Luca, Conte Giuseppe, Russo Domenico, Gorini Antonio, Minutolo Roberto
Format: Article
Language:English
Published: BMC 2012-11-01
Series:BMC Nephrology
Subjects:
Angiotensin converting enzyme inhibitor
Angiotensin II receptor blocker
Renin inhibitor
Paricalcitol
Chronic kidney disease
Proteinuria
Online Access:http://www.biomedcentral.com/1471-2369/13/150

Internet

http://www.biomedcentral.com/1471-2369/13/150

Similar Items